Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    February 2017
  1. IENI A, Angelico G, Zeppa P, Tuccari G, et al
    Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER
    Eur J Cancer. 2017;75:190-191.
    PubMed     Text format    


    December 2016
  2. OH HJ, Lim CH, Yoon BH, Yoon SB, et al
    Fracture after gastrectomy for gastric cancer: A long-term follow-up observational study.
    Eur J Cancer. 2016;72:28-36.
    PubMed     Text format     Abstract available


    August 2016
  3. YOSHINO S, Nishikawa K, Morita S, Takahashi T, et al
    Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Eur J Cancer. 2016;65:164-171.
    PubMed     Text format     Abstract available


    July 2016
  4. TSAI MM, Wang CS, Tsai CY, Huang CG, et al
    Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Eur J Cancer. 2016;64:137-148.
    PubMed     Text format     Abstract available


    May 2016
  5. YOSHIKAWA T, Morita S, Tanabe K, Nishikawa K, et al
    Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric
    Eur J Cancer. 2016;62:103-111.
    PubMed     Text format     Abstract available


  6. BANDO H, Doi T, Muro K, Yasui H, et al
    A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201).
    Eur J Cancer. 2016;62:46-53.
    PubMed     Text format     Abstract available


    April 2016
  7. MONTALVO-JAVE EE, Olguin-Martinez M, Hernandez-Espinosa DR, Sanchez-Sevilla L, et al
    Role of NADPH oxidases in inducing a selective increase of oxidant stress and cyclin D1 and checkpoint 1 over-expression during progression to human gastric adenocarcinoma.
    Eur J Cancer. 2016;57:50-7.
    PubMed     Text format     Abstract available


    December 2015
  8. PARK SR, Park YS, Ryu MH, Ryoo BY, et al
    Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1).
    Eur J Cancer. 2015;53:42-50.
    PubMed     Text format     Abstract available


  9. LEE HH, Park JM, Song KY, Choi MG, et al
    Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.
    Eur J Cancer. 2015;52:129-137.
    PubMed     Text format     Abstract available


    November 2015
  10. FANG X, Wei J, He X, An P, et al
    Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies.
    Eur J Cancer. 2015 Nov 14. pii: S0959-8049(15)00856.
    PubMed     Text format     Abstract available


    September 2015
  11. SYLVIE L, Silvia S, Salah-Eddin AB, Markus F, et al
    Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer.
    Eur J Cancer. 2015;51:1918-26.
    PubMed     Text format     Abstract available


    June 2015
  12. ARNOLD M, Karim-Kos HE, Coebergh JW, Byrnes G, et al
    Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory.
    Eur J Cancer. 2015;51:1164-87.
    PubMed     Text format     Abstract available


    March 2015
  13. NISHIKAWA K, Fujitani K, Inagaki H, Akamaru Y, et al
    Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
    Eur J Cancer. 2015 Mar 18. pii: S0959-8049(15)00209.
    PubMed     Text format     Abstract available


  14. LORENZEN S, Riera Knorrenschild J, Haag GM, Pohl M, et al
    Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
    Eur J Cancer. 2015;51:569-76.
    PubMed     Text format     Abstract available


    February 2015
  15. ROCKEN C, Behrens HM
    Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - A critical appraisal.
    Eur J Cancer. 2015 Feb 11. pii: S0959-8049(15)00099.
    PubMed     Text format     Abstract available


  16. RYU MH, Yoo C, Kim JG, Ryoo BY, et al
    Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.
    Eur J Cancer. 2015 Feb 3. pii: S0959-8049(15)00004.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: